← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1979Last known activity
Aug 1, 2025
Timeline
1960s
- Jan 1, 1968
National Eye Institute (NEI)— Founded
Drugs by trial phase (135 distinct, 192 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (77 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Albinism
- Albinism, Oculocutaneous
- Amblyopia
- Anisometropia
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Atherosclerosis
- Atrophy
- Autoimmune Diseases
- Behcet Syndrome
- Birth Weight
- Blepharitis
- Blindness
- Bronchopulmonary Dysplasia
- Cardiovascular Diseases
- Cataract
- Central Serous Chorioretinopathy
- Chlamydia Infections
- Choroidal Neovascularization
- Color Vision Defects
- Cone Dystrophy
- Cone-Rod Dystrophies
- Corneal Ulcer
- Coronary Disease
- Cystinosis
- Cytomegalovirus Retinitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Dry Eye Syndromes
- Edema
- Eye Diseases
- Eye Infections
- Eye Infections, Fungal
- Geographic Atrophy
- Glaucoma
- Glaucoma, Open-Angle
- Graft vs Host Disease
- Hemorrhage
- Herpes Simplex
- Herpes Zoster
- Herpes Zoster Ophthalmicus
- HIV Infections
- Hypercholesterolemia
- Hypertension
- Immunologic Deficiency Syndromes
- Inflammation
- Intracranial Hypertension
- Iridocyclitis
- Iritis
- Keratitis
- Keratitis, Herpetic
- Keratoconjunctivitis
- Keratoconjunctivitis Sicca
- Leber Congenital Amaurosis
- Macular Degeneration
- Macular Edema
- Multiple Sclerosis
- Mycoses
- Myopia
- Neovascularization, Pathologic
- Neuritis
- Niemann-Pick Diseases
- Niemann-Pick Disease, Type A
- Niemann-Pick Disease, Type C
- Ophthalmia Neonatorum
- Optic Atrophy, Hereditary, Leber
- Optic Nerve Diseases
- Optic Neuritis
- Pick Disease of the Brain
- Premature Birth
- Pseudotumor Cerebri
- Retinal Degeneration
- Retinal Detachment
- Retinal Diseases
- Retinal Drusen
- Retinal Dystrophies
- Retinal Vein Occlusion
- Retinitis
- Retinitis Pigmentosa
- Retinopathy of Prematurity
- Scleritis
- Sjogren's Syndrome
- Strabismus
- Syndrome
- Telangiectasis
- Trachoma
- Trichiasis
- Ulcer
- Uveitis
- Uveitis, Anterior
- Uveitis, Posterior
- Vaccinia
- Vascular Remodeling
- Vitreoretinopathy, Proliferative
- Vitreous Hemorrhage
- von Hippel-Lindau Disease
Recent trials (50)
- NCT06919081CollaboratorPhase 2Aug 1, 2025
- NCT06790784CollaboratorPhase 3Mar 31, 2025
- NCT06289647CollaboratorPhase 4Jul 28, 2024
- NCT06213649CollaboratorPhase 3Jul 1, 2024
- NCT05904028CollaboratorPhase 3Nov 9, 2023
- NCT05537220CollaboratorPhase 3Feb 28, 2023
- NCT05204329CollaboratorEarly Phase 1Dec 1, 2022
- NCT05110001CollaboratorPhase 3Jan 31, 2022
- NCT04627428CollaboratorPhase 1/Phase 2Dec 31, 2021
- NCT04634604CollaboratorPhase 3Apr 30, 2021
- NCT04634578CollaboratorPhase 2Apr 30, 2021
- NCT04661358CollaboratorPhase 3Mar 5, 2021
- NCT04545736Lead sponsorPhase 1/Phase 2Jan 8, 2021
- NCT04545736Overall official - principal investigatorPhase 1/Phase 2Jan 8, 2021
- NCT04505566CollaboratorPhase 1Nov 9, 2020
Details
- Founded
- Bethesda, Maryland, US Jan 1, 1968
- Last known activity
- Aug 1, 2025